Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Larson

Showing results (21-30 of 1,403) with videos related to

Pageof 141
Sort By:
Applied and Environmental Microbiology|December 1, 1979
Estimation of biodegradation potential of xenobiotic organic chemicalsR J Larson
Lancet (London, England)|October 15, 2013
The Minamata Convention on Mercury: risk in perspectiveHeidi J Larson
Nature Human Behaviour|November 23, 2022
Defining and measuring vaccine hesitancyHeidi J Larson
Human Vaccines & Immunotherapeutics|July 31, 2013
Negotiating vaccine acceptance in an era of reluctanceHeidi J Larson
Nature|April 2, 2020
Blocking information on COVID-19 can fuel the spread of misinformationHeidi J Larson
The Lancet. Public Health|April 4, 2020
Japan's HPV vaccine crisis: act now to avert cervical cancer cases and deathsHeidi J Larson
Science (New York, N.Y.)|September 17, 2016
Vaccine trust and the limits of informationHeidi J Larson
The Journal of General Psychology|December 24, 2002
Behavioral and motivational effects of immune-system activationSusan J Larson
Clinical Neurosurgery|January 1, 1980
Unstable thoracic fractures: treatment alternatives and the role of the neurosurgeonS J Larson
Surgery, Gynecology & Obstetrics|August 1, 1983
Somatosensory evoked potentials in lumbar stenosisS J Larson
Pageof 141

Showing results (21-30 of 1,403) with videos related to

Sort By:
Pageof 141
Applied and Environmental Microbiology|December 1, 1979
Estimation of biodegradation potential of xenobiotic organic chemicalsR J Larson
Lancet (London, England)|October 15, 2013
The Minamata Convention on Mercury: risk in perspectiveHeidi J Larson
Nature Human Behaviour|November 23, 2022
Defining and measuring vaccine hesitancyHeidi J Larson
Human Vaccines & Immunotherapeutics|July 31, 2013
Negotiating vaccine acceptance in an era of reluctanceHeidi J Larson
Nature|April 2, 2020
Blocking information on COVID-19 can fuel the spread of misinformationHeidi J Larson
The Lancet. Public Health|April 4, 2020
Japan's HPV vaccine crisis: act now to avert cervical cancer cases and deathsHeidi J Larson
Science (New York, N.Y.)|September 17, 2016
Vaccine trust and the limits of informationHeidi J Larson
The Journal of General Psychology|December 24, 2002
Behavioral and motivational effects of immune-system activationSusan J Larson
Clinical Neurosurgery|January 1, 1980
Unstable thoracic fractures: treatment alternatives and the role of the neurosurgeonS J Larson
Surgery, Gynecology & Obstetrics|August 1, 1983
Somatosensory evoked potentials in lumbar stenosisS J Larson
Pageof 141